← Open Payments lookup

THOMAS KOSH: Open Payments

NPI 1881061208 · ROWLETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,033 in 86 payments from 29 companies in 2025. Trend: 2023 $2,387 · 2024 $4,109 · 2025 $3,033

Food & beverage: $1,763Long term medical supply or device loan: $1,000Education: $270
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation13$1,029
Daiichi Sankyo Inc.7$375
Janssen Biotech, Inc.5$182
E.R. Squibb & Sons, L.L.C.10$170
Tempus AI, Inc6$142
PFIZER INC.4$100
ABBVIE INC.3$83
AstraZeneca Pharmaceuticals LP3$83
Karyopharm Therapeutics Inc.3$81
Geron Corporation3$75

Products named: KISQALI, ENHERTU, XT CDX, ERLEADA, OPDIVO, XPOVIO, RYTELO, Nubeqa.

Industry payments across TX — which companies pay providers there.